Aug 9, 2021 | Comparative Effectiveness, Generic Drugs, MedBen Rx, Prescription drugs, Rx Costs, Rx Spending, Savings
Generic doesn’t always mean cheap. As this list recently compiled by GoodRx demonstrates, the monthly cost of some popular generic drugs can actually rival or exceed well-known brand medications. MedBen Rx comparative effectiveness ensures that members are using the...
Jul 12, 2021 | MedBen Rx, Pharmacy Benefits Manager (PBM), Rx Costs, Savings, Transparency
Lack of disclosure is a common theme for many pharmacy benefit managers (PBMs), be it with employers or state governments. From Benefits Pro: “At least a half-dozen states and the District of Columbia are investigating pharmacy benefit managers, The Wall Street...
Jun 28, 2021 | Announcements, Client Report, MedBen Rx, Prescription drugs, Rebates, Rx Costs, Rx Spending, Savings
The 2021 MedBen Client Report is now available for download at MedBen.com. In addition to detailing the ways that our clients are spending less on health care, this year’s Client Report highlights the priority MedBen places on client service: Members connect to a...
Jun 14, 2021 | Brand Name Drugs, Comparative Effectiveness, MedBen Rx, Prescription drugs, Rx Costs, Savings, Specialty Drugs
The prices of 260 popular brand-name prescription drugs rose 3% from 2019 to 2020 – twice as much as the 1.3% rate of inflation during the same period, according to a new AARP report. Their analysis also found that over the past 15 years, prices of 65 common brands...
Jun 1, 2021 | Formularies, MedBen Rx, Pharmacy Benefits Manager (PBM), Prescription drugs, Savings, Transparency
MedBen Rx clients save 21.6% when switching from traditional PBMs. What accounts for such a substantial difference? With MedBen Rx you pay what the pharmacy pays – we use the drug’s acquisition cost as a baseline to reduce your costs. MedBen Rx offers total...
May 17, 2021 | Comparative Effectiveness, MedBen Rx, Pharmacy Benefits Manager (PBM), Prescription drugs, Savings
MedBen Rx clients can save between 10-30% by using comparative effectiveness focusing on the best drug outcomes. One way it does this is by dispelling the costly misperception that “new is better.” “A new FDA approved drug doesn’t mean it’s better than existing...
